This congress is the single most senior-level focused event in Europe, dedicated to key technological and scientific advances in the proteins industry. As the only conference to bring together all the experts in the biopharmaceutical industry, this exciting meeting is a must attend for anyone working in the field of proteins and antibodies. 

 

Over  two days, the event will attract over 220 senior decision makers from Europe and the US with a comprehensive conference program featuring four separate streams, keynote addresses, case study presentations and interactive panel discussions given by over 45 expert speakers from leading pharmaceutical, biotech, academic and research institutes.

 

On Day One, the congress will address the most pressing challenges in protein purification, expression and characterisation through a series of cutting-edge conference presentations. Our antibody experts debate the future of bispecific antibodies, novel screening technologies, and next generation antibody discovery techniques.

 

On Day Two, learn more about current developments in selecting the optimal biotherapeutic candidate, extending half life and overcoming immunogenicity and aggregation challenges. Do not miss out on the chance to discover innovative solutions to increasing the clinical success rate of engineered antibodies and targeting difficult receptors. 

 

The 7^th Annual Proteins Congress is co-located with the highly successful 2^nd Annual Biosimilars & Biobetters Congress and the Peptides Congress.

 

Oxford Global are offering a 20% discount on delegate passes until 20th December 2013. (Industry and academic institutions only) Do not miss out on this exclusive offer. Access into all three events from one booking.

 

Click here to download the agendas and to receive the 20% discount, alternatively contact Danielle Dalby at d.dalby@oxfordglobal.co.uk